Emerging clinical demand Target potential collaborations in urology, cardiology, neurology and oncology research, leveraging their broad clinical scope and 20+ years in trials to expand study capabilities and diversify sponsorship opportunities.

Mid-market focus Position as a nimble partner for mid-sized sponsors and CROs seeking high-touch, specialized sites with manageable team size (11-50 employees) while offering competitive engagement in early-phase to late-phase studies.

Growth via new studies Capitalize on their recent low testosterone study as a case model to attract sponsor interest in endocrinology and metabolic disorders, highlighting end-to-end management from enrollment to data capture.

Digital enablement Leverage existing tech stack (WordPress, Mailchimp, Office 365) to showcase capabilities, patient communications, and trial management efficiencies; propose digital patient recruitment and retention packages to sponsors.

Revenue expansion With demonstrated revenue between one and ten million, target tiered sponsorships and multi-site partnering opportunities, offering scalable engagement models to grow both revenue and site utilization.